Filter News
Area of Research
News Topics
- (-) Biomedical (2)
- (-) Fusion (3)
- (-) Isotopes (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (4)
- Artificial Intelligence (8)
- Bioenergy (2)
- Biology (2)
- Chemical Sciences (2)
- Climate Change (2)
- Computer Science (11)
- Cybersecurity (13)
- Decarbonization (1)
- Energy Storage (1)
- Environment (1)
- Exascale Computing (1)
- Frontier (1)
- Grid (2)
- High-Performance Computing (1)
- Machine Learning (6)
- Materials (1)
- Materials Science (2)
- National Security (21)
- Neutron Science (3)
- Nuclear Energy (13)
- Partnerships (4)
- Physics (3)
- Quantum Science (1)
- Security (7)
- Space Exploration (2)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
- Transportation (1)
Media Contacts
A partnership of ORNL, the Tennessee Department of Economic and Community Development, the Community Reuse Organization of East Tennessee and TVA that aims to attract nuclear energy-related firms to Oak Ridge has been recognized with a state and local economic development award from the Federal Laboratory Consortium.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
As a teenager, Kat Royston had a lot of questions. Then an advanced-placement class in physics convinced her all the answers were out there.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.